UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas

Stoyanova lab is excited to share our new publication on Cell Reports Medicine on revealing mechanisms of UCHL1 function in regulating the progression of neuroendocrine carcinomas and identifying UCHL1 as a therapeutic target and potential molecular indicator for diagnosing and monitoring treatment responses in these malignancies.


Link to Publication: https://www.cell.com/cell-reports-medicine/pdf/S2666-3791(23)00610-9.pdf